The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
The FDA's Purple Book is the official source for tracking biosimilars and interchangeable biological products. Learn how it works, why interchangeability matters, and how state laws affect pharmacy substitutions.
Read More